SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-028781
Filing Date
2024-02-28
Accepted
2024-02-28 16:58:07
Documents
18
Period of Report
2024-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm247234d1_8k.htm   iXBRL 8-K 54606
2 EXHIBIT 2.1 tm247234d1_ex2-1.htm EX-2.1 574806
3 EXHIBIT 99.1 tm247234d1_ex99-1.htm EX-99.1 95162
4 EXHIBIT 99.2 tm247234d1_ex99-2.htm EX-99.2 17803
8 GRAPHIC tm247234d1_ex99-2img001.jpg GRAPHIC 19726
  Complete submission text file 0001104659-24-028781.txt   1106635

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA sctl-20240228.xsd EX-101.SCH 3027
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE sctl-20240228_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sctl-20240228_pre.xml EX-101.PRE 22367
19 EXTRACTED XBRL INSTANCE DOCUMENT tm247234d1_8k_htm.xml XML 3487
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Societal CDMO, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 24696490
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)